Pinnacle Financial Partners (Tennessee)’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-212	Closed	-$223K	–	527
2024 Q3	$223K	Buy	212 +18	+9%	+$20K	﹤0.01%	418
2024 Q2	$204K	Buy	+194	New	+$188K	﹤0.01%	431
2016 Q1	–	Sell	-960	Closed	-$521K	–	266
2015 Q4	$521K	Buy	960 +32	+3%	+$17.3K	0.16%	149
2015 Q3	$432K	Hold	928	–	–	0.14%	151
2015 Q2	$473K	Hold	928	–	–	0.15%	143
2015 Q1	$419K	Sell	928 -577	-38%	-$245K	0.14%	148
2014 Q4	$617K	Hold	1,505	–	–	0.22%	119
2014 Q3	$543K	Sell	1,505 -290	-16%	-$97.2K	0.21%	116
2014 Q2	$507K	Hold	1,795	–	–	0.2%	118
2014 Q1	$539K	Hold	1,795	–	–	0.24%	106
2013 Q4	$494K	Sell	1,795 -35	-2%	-$10.1K	0.23%	108
2013 Q3	$572K	Buy	1,830 +250	+16%	+$65.8K	0.28%	87
2013 Q2	$355K	Buy	+1,580	New	+$368K	0.18%	96